Amgen had 17 patents in future of work during Q2 2024. Amgen Inc has developed automatic syringe quality control systems, a real-time drug injection time duration measurement system, and a drug product reconstitution processing system. These systems utilize digital image data to determine plunger depth in pre-filled syringes, sound transducers to measure drug delivery initiation and completion, and robotic arms to transfer, agitate, and reconstitute drug vials. GlobalData’s report on Amgen gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Amgen had no grants in future of work as a theme in Q2 2024.
Recent Patents
Application: Methods and systems for automated syringe quality evaluation (Patent ID: US20240210428A1)
The patent filed by Amgen Inc. describes an automatic syringe quality control system that utilizes digital image data to determine the plunger depth within a pre-filled syringe. The system involves aligning the syringe on an imaging surface, capturing an image of the syringe, measuring the plunger depth, and determining if it falls within a predetermined tolerance. The method allows for rapid verification of syringe quality, with additional features such as using a digital optical comparator and aligning a planar portion of the syringe barrel for accurate measurements.
Furthermore, the patent also covers a method for analyzing multiple syringes simultaneously by providing an alignment device for multiple syringes, capturing images of the syringes, measuring the plunger depth of each syringe, and determining if they meet the predetermined tolerance. The system includes features like a digital optical comparator, illuminated silhouette images, and the ability to generate and store syringe quality data. Additionally, the patent includes details about an automatic syringe measurement system with an imaging system, alignment device, and processor to ensure accurate plunger depth measurements within a syringe barrel.
To know more about GlobalData’s detailed insights on Amgen, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
